Suchergebnisse - "Wasserman, Sean"

PubPharm (7)

1

Genotype-Phenotype Characterization of Serial Mycobacterium tuberculosis Isolates in Bedaquiline-Resistant Tuberculosis

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2024

von Brown, T. | Tang, L. | Omar, S. | +10

2

Model-Predicted Impact of ECG Monitoring Strategies During Bedaquiline Treatment

enthalten in: Open forum infectious diseases | 2022

von van Beek, S. | Tanneau, L. | Meintjes, G. | +9

3

Pharmacogenetics of Between-Individual Variability in Plasma Clearance of Bedaquiline and Clofazimine in South Africa

enthalten in: The Journal of infectious diseases | 2022

von Haas, D. | Abdelwahab, M. | van Beek, S. | +11

4

Effectiveness and Cardiac Safety of Bedaquiline-Based Therapy for Drug-Resistant Tuberculosis : A Prospective Cohort Study

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2021

von Brust, J. | Gandhi, N. | Wasserman, S. | +18

5

Relationship between Plasma and Intracellular Concentrations of Bedaquiline and Its M2 Metabolite in South African Patients with Rifampin-Resistant Tuberculosis

enthalten in: Antimicrobial agents and chemotherapy | 2021

von Ngwalero, P. | Brust, J. | van Beek, S. | +11

6

Improved Treatment Outcomes With Bedaquiline When Substituted for Second-line Injectable Agents in Multidrug-resistant Tuberculosis : A Retrospective Cohort Study

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2019

von Zhao, Y. | Fox, T. | Manning, K. | +9

7

Recent controversies about MDR and XDR-TB : Global implementation of the WHO shorter MDR-TB regimen and bedaquiline for all with MDR-TB?

enthalten in: Respirology (Carlton, Vic.) | 2018

von Dheda, K. | Cox, H. | Esmail, A. | +3

CommentIn: Respirology. 2018 Jun;23(6):636-637. - PMID 29701300

1
[1]